(19)
(11) EP 4 798 302 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24793866.5

(22) Date of filing: 24.10.2024
(51) International Patent Classification (IPC): 
A61P 17/00(2006.01)
C07D 209/44(2006.01)
C07D 403/14(2006.01)
C07D 417/14(2006.01)
C07D 487/10(2006.01)
A61P 29/00(2006.01)
C07D 403/10(2006.01)
C07D 413/14(2006.01)
C07D 471/10(2006.01)
A61K 31/4045(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 403/10; C07D 487/10; C07D 471/10; C07D 403/14; C07D 413/14; C07D 417/14; C07D 209/44; A61P 17/00; A61P 29/00
(86) International application number:
PCT/EP2024/080147
(87) International publication number:
WO 2025/088073 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 24.10.2023 EP 23205641

(71) Applicants:
  • Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    80686 München (DE)
  • Johann-Wolfgang-Goethe-Universität Frankfurt am Main
    60323 Frankfurt am Main (DE)

(72) Inventors:
  • HERNANDEZ-OLMOS, Victor
    80686 München (DE)
  • HEERING, Jan
    80686 München (DE)
  • PROSCHAK, Eugen
    80686 München (DE)
  • STEINHILBER, Dieter
    80686 München (DE)
  • WEIGERT, Andreas
    60323 Frankfurt am Main (DE)

(74) Representative: Kuttenkeuler, David 
SKM-IP PartGmbB Oberanger 45
80331 München
80331 München (DE)

   


(54) HETEROCYCLIC COMPOUNDS AS BLT2 AGONISTS AND THEIR MEDICAL USE